NERV - Minerva Neurosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development34,888.57430,255.89220,439.99418,533.363
Selling General and Administrative16,841.30810,914.2699,750.7027,576.256
Non Recurring----
Others----
Total Operating Expenses51,729.88241,170.16130,190.69626,109.619
Operating Income or Loss-51,729.882-41,170.161-30,190.696-26,109.619
Income from Continuing Operations
Total Other Income/Expenses Net1,558.595270.682-854.676-972.013
Earnings Before Interest and Taxes-51,729.882-41,170.161-30,190.696-26,109.619
Interest Expense-110.448-614.264-1,029.734-1,053.07
Income Before Tax-50,171.287-40,899.479-31,045.372-27,081.632
Income Tax Expense--9,376.272--
Minority Interest----
Net Income From Continuing Ops-50,171.287-31,523.207-31,045.372-27,081.632
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-50,171.287-31,523.207-31,045.372-27,081.632
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-50,171.287-31,523.207-31,045.372-27,081.632